Iams, W. T., Yu, H., Shyr, Y., Patil, T., Horn, L., McCoach, C., . . . Camidge, D. R. (2018). First line chemotherapy responsiveness and patterns of metastatic spread identify clinical syndromes present within advanced KRAS mutant non-small cell lung cancer with different prognostic significance. Clin Lung Cancer.
Styl ChicagoIams, Wade T., Hui Yu, Yu Shyr, Tejas Patil, Leora Horn, Caroline McCoach, Karen Kelly, Robert C. Doebele, a D. Ross Camidge. "First Line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-small Cell Lung Cancer With Different Prognostic Significance." Clin Lung Cancer 2018.
Citace podle MLAIams, Wade T., et al. "First Line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-small Cell Lung Cancer With Different Prognostic Significance." Clin Lung Cancer 2018.